The pharmaceutical industry imports in Italy have shown a dynamic trend from 2013 to 2023. In 2023, imports stood at 36.25 Billion US Dollars. During the last decade, the imports started at 24.72 Billion US Dollars in 2013 and fluctuated until seeing more consistent growth after 2017. Notable year-on-year variations include substantial increases in 2018 (14.33%) and 2021 (5.95%). The compound annual growth rate (CAGR) over the last five years reflects a robust annual average growth rate of 3.88%. Forecasts suggest continued growth, with a five-year CAGR of 2.49% leading to a projected import value of 42.42 Billion US Dollars by 2028.
Future trends to watch for include the impact of regulatory changes, advancements in pharmaceutical technology, and potential shifts due to geopolitical factors. The increasing demand for high-quality healthcare products and the expansion of the biotech sector in Italy are expected to drive further growth in import values.
